Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Toxicogenomic profiling of chemically exposed humans in risk assessment.

McHale CM, Zhang L, Hubbard AE, Smith MT.

Mutat Res. 2010 Dec;705(3):172-83. doi: 10.1016/j.mrrev.2010.04.001. Epub 2010 Apr 9. Review.

2.

Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.

Kienhuis AS, Bessems JG, Pennings JL, Driessen M, Luijten M, van Delft JH, Peijnenburg AA, van der Ven LT.

Toxicol Appl Pharmacol. 2011 Jan 15;250(2):96-107. doi: 10.1016/j.taap.2010.10.013. Epub 2010 Oct 21. Review.

PMID:
20970440
3.

Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.

Goetz AK, Singh BP, Battalora M, Breier JM, Bailey JP, Chukwudebe AC, Janus ER.

Regul Toxicol Pharmacol. 2011 Nov;61(2):141-53. doi: 10.1016/j.yrtph.2011.07.012. Epub 2011 Aug 5.

PMID:
21840362
4.

Toxicogenomic approach for assessing toxicant-related disease.

Waters MD, Olden K, Tennant RW.

Mutat Res. 2003 Nov;544(2-3):415-24. Review.

PMID:
14644344
5.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
6.

Systems biology of human benzene exposure.

Zhang L, McHale CM, Rothman N, Li G, Ji Z, Vermeulen R, Hubbard AE, Ren X, Shen M, Rappaport SM, North M, Skibola CF, Yin S, Vulpe C, Chanock SJ, Smith MT, Lan Q.

Chem Biol Interact. 2010 Mar 19;184(1-2):86-93. doi: 10.1016/j.cbi.2009.12.011. Epub 2009 Dec 21. Review.

7.

Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.

Youns M, Hoheisel JD, Efferth T.

Planta Med. 2010 Dec;76(17):2019-25. doi: 10.1055/s-0030-1250432. Epub 2010 Oct 18. Review.

PMID:
20957595
8.

[Evolution of industrial toxicology toward vanishing doses and the human genome].

Colombi A, Buratti M, Rubino FM, Giampiccolo R, Pulvirenti S, Brambilla G.

Med Lav. 2003 Jan-Feb;94(1):69-82. Review. Italian.

PMID:
12768958
9.

Gene expression profiling to identify potentially relevant disease outcomes and support human health risk assessment for carbon black nanoparticle exposure.

Bourdon JA, Williams A, Kuo B, Moffat I, White PA, Halappanavar S, Vogel U, Wallin H, Yauk CL.

Toxicology. 2013 Jan 7;303:83-93. doi: 10.1016/j.tox.2012.10.014. Epub 2012 Nov 9.

10.

State-of-the-art genomics approaches in toxicology.

Van Hummelen P, Sasaki J.

Mutat Res. 2010 Dec;705(3):165-71. doi: 10.1016/j.mrrev.2010.04.007. Epub 2010 May 11. Review.

PMID:
20466069
11.

Toxicogenomics: regulatory perspective on current position.

Battershill JM.

Hum Exp Toxicol. 2005 Jan;24(1):35-40. Review.

PMID:
15727054
12.

Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.

Waters M, Boorman G, Bushel P, Cunningham M, Irwin R, Merrick A, Olden K, Paules R, Selkirk J, Stasiewicz S, Weis B, Van Houten B, Walker N, Tennant R.

EHP Toxicogenomics. 2003 Jan;111(1T):15-28.

PMID:
12735106
13.

Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.

Aardema MJ, MacGregor JT.

Mutat Res. 2002 Jan 29;499(1):13-25. Review.

PMID:
11804602
14.

Application of toxicogenomic profiling to evaluate effects of benzene and formaldehyde: from yeast to human.

McHale CM, Smith MT, Zhang L.

Ann N Y Acad Sci. 2014 Mar;1310:74-83. doi: 10.1111/nyas.12382. Epub 2014 Feb 26. Review.

15.

Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.

Wilson VS, Keshava N, Hester S, Segal D, Chiu W, Thompson CM, Euling SY.

Toxicol Appl Pharmacol. 2013 Sep 15;271(3):299-308. doi: 10.1016/j.taap.2011.01.017. Epub 2011 Feb 2. Review.

PMID:
21295051
16.

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.

Heijne WH, Kienhuis AS, van Ommen B, Stierum RH, Groten JP.

Expert Rev Proteomics. 2005 Oct;2(5):767-80. Review.

PMID:
16209655
17.

How can toxicogenomics inform risk assessment?

Oberemm A, Onyon L, Gundert-Remy U.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):592-8. Review.

PMID:
15990130
18.

Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.

Waters MD, Jackson M, Lea I.

Mutat Res. 2010 Dec;705(3):184-200. doi: 10.1016/j.mrrev.2010.04.005. Epub 2010 Apr 24. Review.

PMID:
20399889
19.

The impact of new technologies on human population studies.

Waters MD, Selkirk JK, Olden K.

Mutat Res. 2003 Nov;544(2-3):349-60. Review.

PMID:
14644337
20.

Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.

Luebke RW, Holsapple MP, Ladics GS, Luster MI, Selgrade M, Smialowicz RJ, Woolhiser MR, Germolec DR.

Toxicol Sci. 2006 Nov;94(1):22-7. Epub 2006 Aug 1.

Items per page

Supplemental Content

Write to the Help Desk